Chordomas are rare tumors arising from the remnants of the notochord. They comprise less than 0.2% of primary intracranial tumors and are found throughout the axial skeleton from the skull base to the sacrum. The sacrum and the skull base are the most common sites. These tumors are generally regarded as malignant; the local recurrence rate is high, but the rate of distant metastasis is relatively low (5-20%). Chordomas are generally regarded as lethal, with a 5-year survival rate reported at 70%. Aggressive excision is ideal in providing long-term tumor control or even cure, but the procedure is associated with a morbidity rate. Irradiation, in various forms, has been used with variable results. To date, the use of adjunctive, proton beam irradiation has been shown to offer the best long-term tumor control associated with minimal morbidity. We have reviewed our experience with the management of 34 patients with skull base chordomas over a 9-year period.
a balloon occlusion test to evaluate the collateral reserve of the cerebral circulation. This test was performed during the diagnostic arteriography by using clinical neurological assessment to determine the patient's tolerance.
Radical Excision
The patients underwent surgery in which modern skull base techniques were used; the procedures were performed in one or two planned stages to accomplish total resection of the tumor as well as the surrounding bone. A variety of skull base approaches was used depending on the location and size of the tumor. 1, 6 The adequacy of resection was noted based on the surgeon's observation and findings on the postoperative MR and CT studies. Postoperatively the patients underwent annual follow-up MR or CT studies and clinical examination. Recurrent tumor was judged according to findings on imaging studies. All tumors were evaluated by a neuropathologist, and the diagnosis of chordoma was confirmed using the histological criteria reported by Heffelfinger, et al. 7 In cases in which a chondroid chordoma could not be definitively differentiated from a chondrosarcoma, immunohistochemical analysis was used to confirm the diagnosis (chordomas are epithelial tumors that are positive for cytokeratin and epithelial membrane antigen.
)

Adjuvant Treatment
Five patients had undergone radiotherapy prior to the present surgery, and eight additional patients underwent radiotherapy after our surgery. Of those who underwent radiotherapy prior to our surgery, two patients underwent fractionated external beam irradiation; two underwent proton and photon radiotherapy; and one underwent external beam and brachytherapy at separate sittings. Of those who received radiation treatment for residual disease after our surgery, four patients underwent fractionated external beam irradiation; three underwent proton beam radiotherapy; and one underwent linear accelerator radiosurgery. Only one patient received chemotherapy, which was administered for recurrent disease.
RESULTS
Areas of Tumor Involvement, Degree of Resection, and Number of Operations
Total resection, as determined by imaging study findings and intraoperative inspection, was accomplished in 18 patients. In the remaining 11 patients incomplete resection was achieved. Of those in whom total resection tumor was achieved, three had undergone a previous surgical treatment, whereas four of the 11 patients in whom incomplete resection was accomplished had undergone a previous surgery.
In the eight patients in whom a previous surgery had been performed elsewhere 13 operations were perfromed prior to presenting to our institution: five patients had undergone one operation; two, two operations; and one, four operations. When the patient was referred to The Mount Sinai Hospital, the procedure to resect the chordoma was performed in one or two stages, depending on the anatomical extent of the disease. Thus, there were 43 operations for tumor resection in 29 patients: 15 patients underwent a single operation, whereas 14 patients underwent twostage operations for removal of the chordoma. The surgical strategy and choice of approaches for tumor resection have been described previously. 6, 15 The anatomical areas of involvement and the important structures involved are noted in Table 2 .
Length of Stay in the ICU
Length of stay in the ICU after surgery was reflective of postoperative complications. For 24 patients the mean LOS in the ICU was 4.3 days (range 1-10 days). For five patients LOS was inordinately long, with a mean 44.4 days (cumulative) and range of 22 to 98 days. These five patients harbored very large tumors, and four were older than 65 years of age. Two had undergone prior operations and radiotherapy. In two patients CSF leaks and meningitis or wound infection developed. One had poor pulmonary function preoperatively and required long-term ventilatory support because of a temporal lobe hematoma which caused impairment of his sensorium, and was surgically evacuated.
Complications and Treatment
A summary of complications in this group of patients is C. Sen and A. Triana provided in Table 3 . Cranial nerve impairment was the most frequent surgery-related deficit. These were new deficits or preexisting ones that were aggravated by surgery. Nine patients required reoperations due to these complications: three patients required one, four required two, one required three, and one patient required four operations for the management of their complications. Six patients required the creation of a VP shunt; shunt revision was necessary in two. All these patients harbored large tumors and had undergone more than one operation. Four of them also had previously undergone radiotherapy. Two patients in whom occipitocervical fusion and fixation were performed developed CSF effusion in the wound and subsequent infection. This was treated with a trapezius flap and debridement in one patient and removal of the hardware in the other. Two patients required operative reexploration of their neck wounds after a hematoma developed due to the pedicle of a microvascular free flap that had been used for reconstruction. In two patients CSF leaks developed postoperatively, requiring reexploration and repair; in one the leak developed after a bifrontal craniotomy in which an olfaction-sparing operation 16 had been performed (see Case 1 in Illustrative Cases), and in the other meningitis developed as did a CSF leak that was caused by an inadvertent entry into the middle ear cavity during an anterolateral approach. This was repaired using a temporopareital fascial flap. Another patient developed an epidural abscess secondary to breakdown of a pericranial flap after a bifrontal craniotomy via an extended subfrontal approach. The absess was debrided and the bone flap was removed in one sitting; repair with a rectus abdominis microvascular free flap was performed at a later sitting. This patient also required neck reexploration for a hematoma caused by the free flap pedicle.
In one patient a postoperative temporal lobe hematoma, which was evacuated on the following day, had been caused by progression of an intraoperative temporal lobe contusion. One patient harbored a large chordoma involving both VAs, one of which was occluded by the tumor. The other VA had been inadvertently traumatized during surgery with resultant occlusion. The patient developed ischemic symptoms postoperatively and underwent an urgent revascularization in which a saphenous vein graft was placed from the external CA to the VA; complete resolution of the ischemic problems was demonstrated after this procedure.
Follow-Up Tumor Control and Function
The mean follow-up period was 20.5 months (range 3-77 months) ( Table 4) . Twenty-four patients are alive and five are dead. Three patients harbored very aggressive tumors that grew rapidly at the time of recurrence and progressed despite reoperation and the provision of radiotherapy. They died of progressive, local recurrence of the tumor. One patient, in whom a fourth ventricle tumor was observed, died after refusing any further treatment. This lesion was completely separate from her original tumor site, which had been controlled with radical surgery and irradiation. One patient died in a nursing home after a complicated postoperative course 6 months after surgery for a chordoma that had recurred after surgery and irradiation.
Of the 24 living patients, 21 are free of disease. In the three cases of recurrent disease, the tumor recurred in one patient at a distance from the original disease site due to subarachnoid seeding; in a patient in whom a clival tumor had been resected, recurrence was found in both cavernous sinuses, and the patient underwent proton beam radiotherapy; and one patient has a local recurrence for which he has refused further treatment. All 24 patients are functioning well and are independent for activities of daily living. For the patients with tumor recurrence after surgery at The Mount Sinai Hospital (alive and dead), the mean time of recurrence after our last operation was 16.3 months (range 6-39 months).
A summary of the pre-and postoperative KPS status is provided in Table 5 . Seventeen patients had the same or improved KPS scores after surgery. In 12 patients the KPS
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Radical excision of cranial chordoma 3 scores declined after surgery. In eight patients a loss of 10 KPS points was related to postoperative cranial nerve impairment. A decline of 20 KPS points was observed in three patients who harbored large tumors, two of which had recurred after prior surgery and radiotherapy; the third patient suffers from permanent swallowing impairment after resection of tumor involving both jugular foramina, and this patient requires feeding through a gastrostomy. The only case in which a loss of 40 KPS points was observed occurred in a patient with a very aggressive tumor that recurred rapidly after a third operation. He had also undergone proton beam radiotherapy after his second operation.
ILLUSTRATIVE CASES
Case 1
This 26-year-old woman presented with visual difficulties, difficulty with speech and swallowing, amenorrhea, gait instability, and urinary urgency. On examination, she was observed to have bilateral lateral gaze paresis, rightsided hemiparesis, gait ataxia, and upper-extremity dysmetria. Computerized tomography scanning revealed a large calcified tumor in the clival region with hydrocephalus (Fig. 1) . Magnetic resonance imaging demonstrated severe brainstem and hypothalamic compression (Fig. 2) . A VA shunt was placed, and the patient underwent a two-stage operation. In the first stage a bifrontal craniotomy, supraorbital rim osteotomy, and extended subfrontal approach were performed.
14 The olfactory ap.-paratus was preserved, which limited our ability to reconstruct the floor of the anterior fossa without using a pericranial flap. 16 To prevent a CSF leak, hydroxyapatite cement was used to reconstruct the bone defect in the floor (Fig. 3) . In the second stage a retrolabyrinthine transpetrosal approach was performed; total tumor resection was achieved, and the diseased bone of the clivus was also removed (Fig. 4) . Within 12 months of surgery she developed meningitis three separate times, and CT cisternography demonstrated the site of CSF leakage to be the olfactory apparatus. This was repaired using a pericranial flap, and her olfactory function was sacrificed. She has remained in normal condition (except for anosmia) and free of disease more than 3 years.
Although the tumor involved only a small area of the clival bone, the extended subfrontal extradural approach was used to remove this bone with a wide margin. The second stage of the operation, performed to remove the major bulk of the tumor, was completely intradural, and radiographically demonstrated that total tumor removal was achieved. The attempted preservation of olfaction resulted in incomplete repair of the anterior fossa. This was the site of the CSF leak, which presented a year after the operation and was finally repaired using a pericranial flap and obliteration of the cribriform plate. This patient has not received postoperative radiation therapy.
Case 2
This 24-year-old man presented with two episodes of diplopia secondary to left-sided sixth cranial nerve impairment. computerized tomography and MR imaging studies revealed a destructive lesion in the left petrous apex, clivus, and posterior cavernous sinus (Fig. 5 upper) . The only neurological deficit was that of a mild impairment of the left-sided sixth cranial nerve function. He underwent a single operation via a left frontotemporal approach, and zygomatic osteotomy was performed. A combined extraand intradural approach allowed total tumor resection, as well as removal of the involved bone (Fig. 5 lower) . The tumor was small and therefore radical removal could be achieved via a single surgical approach. In over 6 years of follow up, the patient has not required radiotherapy.
DISCUSSION
Degree of Resection and Surgical Approaches
Chordomas constitute 0.1 to 0.2% of primary intracranial neoplasms. They are regarded as malignant, and there is a strong tendency for local recurrence but a low propensity for distant metastasis. Untreated, a patient with a skull base chordoma rarely survives more than 30 months. 2 Radical resection is generally accepted as the standard treatment for chordomas. 1, 6, 15 Because of the peculiar anatomy of the skull base, radical resection may not be possible or may require extensive operations performed using skull base techniques, which may result in morbidity that is deemed by some to be excessive. 10 The extent of resection clearly influences a patient's long-term survival. 1, 5, 6 Chordomas are predominantly extradural in origin. Although they displace soft tissues and brain, they infiltrate bone at the skull base to a variable extent. Modern skull base techniques and surgical approaches that allow wide access to the base of the tumor have been advocated. 1, 6, 12, 15 Other authors have failed to show an improved outcome with such aggressive approaches. 10, 18 Smaller access, such as that provided by the transsphenoidal approach, has been recommended by some authors. 9, 10 Even with the use of the surgical endoscope, the approaches are very limited and allow adequate access in only a limited number of cases. It has been shown that a wide approach and resection of the tumor base are essential in allowing radical resection, which is important in these lesions. Watkins, et al., 18 have suggested that outcome is largely predetermined by the biological makeup of the tumor. In their review of 38 patients, they concluded that there are two patterns of tumor progression: 1) an aggressive tumor pattern in which the patient dies within 5 years of diagnosis; and 2) an indolent pattern in which the patient harbors a slow-growing tumor.
Routine histopathological examination is a poor prognostic tool to predict aggressive disease behavior or longterm survival. 17 O'Connell, et al., 13 have reviewed 62 chordomas and found that female sex and the presence of more than 10% of tumor necrosis in the pathological specimen were strong predictors of shortened disease-free survival. Eisenberg, et al., 4 have reported that the loss of heterozy-
Neurosurg. Focus / Volume 10 / March, 2001
Radical excision of cranial chordoma gosity of the retinoblastoma gene is associated with more aggressive types of chordomas. Because there is no definitive means by which to differentiate aggressive tumors from those that are slow and indolent, all the tumors have to be treated radically to provide the best chance of longterm control or even cure. It is true, however, that certain particularly aggressive subtypes of chordomas will defy even the most valiant attempt. 1, 18 In the present series in which we used skull base techniques, total resection was accomplished in 18 of the 29 patients.
Surgery-Related Complications
One of the main deterrents of radical surgery has been the associated morbidity. In their report Gay, et al., 6 reported three deaths due to systemic complications. Fortyeight of 60 patients suffered new cranial nerve deficits, although many resolved or improved. Cerebral infarcts and hematomas are direct consequences of the surgical procedures. In the series reported by Gay, et al., there was a 30% incidence of CSF leaks, many of which required surgical repair. They concluded that the increased complications were related to aggressiveness of the resection including the dura, as well as to a history of radiotherapy. Al-Mefty and Borba 1 reported 25 patients in whom modern skull base approaches were used, and only one death occurred. There were five cases of cranial nerve palsy and one case of CSF leakage with meningitis. In their review of 36 patients, Menezes, et al., 12 reported that 33% had undergone prior surgery and 26% prior irradiation. There were no cases of CSF leaks, meningitis, or new cranial nerve deficits. In the present report, cranial nerve deficits were the most common complications. Although only two were new, in many patients there was aggravation of deficits that were only mildly present preoperatively. The incidence of CSF leakage has been low, probably because of the vascularized tissue rotation flaps, such as the pericranial flap and the temporopareital fascial flap, which were often used to reconstruct the defect. These vascularized flaps are very helpful in cases in which a large defect is created in the skull base, because most of the patients have undergone irradiation or will undergo it in the postoperative period. Wound infections often develop in patients with substantial subcutaneous CSF collections. Judicious multilayered wound closure and CSF diversion (VP or lumbar spinal fluid drainage) are useful adjuncts to reduce the incidence of this complication. Many of the complications that require reoperation are preventable, and prevention of such complications can substantially improve the surgery-related outcomes. Complications related to the dissection of the tumors from major arteries or perforating vessels, as well as cranial nerve manipulation, are inevitable to some degree if one is to achieve total tumor removal, which appears to be the ideal goal.
Radiation Treatment
Radiation, in some form or other, has been an integral part of treatment of chordomas. The results of conventional fractionated photon irradiation have not been encouraging. Catton, et al., 3 have reported on 48 patients with chordomas located in the skull base, sacrum, or spine who underwent postoperative irradiation. In 44 of the patients gross disease was present postoperatively at the time of radiotherapy. Except for one patient in whom a response to radiotherapy was demonstrated, all patients suffered progressive disease. There was no difference in the patients receiving less than a 50-Gy dose of radiation compared with those receiving a greater than 50-Gy dose. The authors concluded that patients in whom complete resection was achieved or those with only microscopically residual disease had the best outcome. The availability of proton beam irradiation has certainly improved the results for two reasons: 1) improved imaging allows better identification of the tumor and its surrounding relations, and 2) there is the ability to deliver a high dose of radiation to the target and the ability to minimize radiation to the surrounding structures; however, the target volume plays a very important role. Hug, et al., 8 have reported that the best candidates for proton beam irradiation were those with a tumor volume measuring less than 25 ml. In a series from the Massachusetts General Hospital reported by O'Connell, et al., 13 the critical tumor volume was 70 ml, above which the local failure rate was much higher.
It is thus apparent that for proton beam radiotherapy to be effective the tumor volume must be small and should be identifiable on the imaging studies. The other issue is the timing of treatment: should radiotherapy be undertaken immediately after surgery or when there is evidence of tumor recurrence or residue? The problem with the delivery of radiation to the tumor bed after surgery is that the exact size of the radiation field cannot be accurately defined. If one has to irradiate a larger tumor bed, then the advantage of the proton beam treatment will be lost. It is therefore our practice to initiate radiotherapy when a definite recurrence is noted or if there is a residual tumor that cannot be surgically removed.
Functional Outcome
The postoperative stay in the ICU reflects some of the immediate postoperative problems. The mean LOS in our series was 4.3 days. However, there were five cases that were substantially out of this range. The patients in these cases all harbored large tumors, and four of them were older patients (Ͼ 65 years of age). In two of these patients recurrent tumors were found after surgery and irradiation, in two CSF leaks and infection developed, and in one a temporal lobe hematoma was found. Five patients died of the disease; in all cases the tumors recurred after failed surgery and irradiation, thus underscoring the biology of the tumor. All the remaining patients are functioning well and able to perform their normal daily activities. In the majority of patients preoperative KPS scores were maintained. A reduction of 10 points occurred in eight patients due to aggravation of a cranial nerve or new cranial nerve deficits. The patients for whom the KPS scores showed a decrease of more than 10 points were ultimately the ones that died of disease progression, as mentioned previously.
Gay, et al., 6 reported similar findings in their series. They also noted that majority of the patients with worsened KPS scores demonstrated immediately after surgery recovered in the following 6 to 12 months. Cerebrospinal fluid leakage adversely affects the functional outcome after surgery and therefore must be prevented.
In conclusion, although the follow-up period is short, our experience confirms that an excellent tumor resection can be performed using modern skull base surgical techniques. Smaller and restricted approaches may be useful in some situations and should still be considered in some specific cases; however, only skull base techniques provide the degree of visibility and access to the diseased bone that are often needed in treating these patients. The morbidity involved with such operations is predominantly related to cranial neuropathies, CSF leaks, and woundrelated issues. The cranial neuropathies result from dissecting the tumor from these structures, and most of them recover or improve over time. The CSF leaks and wound complications can be substantially reduced by team work involving a neurosurgeon and an otolaryngology-skull base specialist who are experienced with the various reconstruction techniques. Proton beam irradiation is an excellent adjuvant treatment that provides extended tumor control; however, it should be reserved for use when a definite target (recurrent or residual disease) is identified that is at a distance from the brainstem or the optic system.
